Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease) — Stella

Home/GVHD, Acute/

View on ClinicalTrials.gov

Recruiting

Back to GVHD, Acute trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Department of Hematology, the Fifth Center of Chinese PLA General Hospital, Beijing

Key details

Phase

Safety & dosing

Sponsor

Daihong Liu

Enrollment target

~54 participants

Started

June 2025

Primary completion

December 2027

Age range

14 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.